Hyperglycemia in Acute COVID-19 is Characterized by Insulin Resistance and Adipose Tissue Infectivity by SARS-CoV-2. Reiterer et al.

Published: 10 September 2021| Version 2 | DOI: 10.17632/sckg5ygndm.2
Contributor:
Moritz Reiterer

Description

Supplemental Data Files referenced in "Hyperglycemia in Acute COVID-19 is Characterized by Insulin Resistance and Adipose Tissue Infectivity by SARS-CoV-2" by Reiterer et al.

Files